Asia Pacific In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022120 | No. of Pages: 217 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The In-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027.

The growing healthcare industry in the developing countries in Asia Pacific is creating better opportunities for the major market players to expand their business. Moreover, huge patient population in emerging countries is generating demand for advanced diagnostic systems. For instance, according to the global burden of disease data, India has 18% of the world’s population, but it has 32% of global burden of respiratory diseases. Similarly, according to the new Tulane University study published in 2018, 8.6% of the Chinese population suffers from the chronic lung disease. Additionally, implementation of intense market penetration strategies in the region are anticipated to strengthen the market in the region. For instance, in December 2019, Boditech Med Inc., one of the significant players in the in-vitro diagnostics market entered into Japan market by receiving regulatory approval from Japanese authorities. Thus, growing healthcare sector in the region is likely to boost the market and is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

 

The healthcare industry is growing significantly in this region. The healthcare industry's growth is influenced by the rising number of startups in the in-vitro diagnostics and other healthcare segments. Despite the destruction made by the pandemic, countries have experienced excellent growth opportunities. Countries like India, Japan, and South Korea have emerged as developers of various innovative technologies to detect COVID-19 infection. Various small players have received authorities to manufacture point of care diagnostics and in-vitro diagnostics test systems. In addition, in India, the development of vaccines has attracted various investors to invest in the region's healthcare system and leverage the market's growth in the following years.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The Asia Pacific In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :



Asia Pacific In-Vitro Diagnostics Market Segmentation  

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific

 

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          In-Vitro Diagnostics Market – By Product and Services

1.3.2          In-Vitro Diagnostics Market – By Technology

1.3.3          In-Vitro Diagnostics Market – By Application

1.3.4          In-Vitro Diagnostics Market – By End User

1.3.5          Asia Pacific In-Vitro Diagnostics Market – By Country

2.           Asia Pacific In-Vitro Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Asia Pacific In-Vitro Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          In-Vitro Diagnostics Market- Asia Pacific PEST Analysis

4.3          Expert Opinion

5.           Asia Pacific In-Vitro Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Prevalence of Chronic and Infectious Diseases

5.1.2          Growing Geriatric Population

5.1.3          Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic

5.2          Market Restraints

5.2.1          Lack of Healthcare Infrastructure and Reimbursement Policies

5.3          Market Opportunities

5.3.1          Emerging Markets in Developing Countries

5.4          Future Trends

5.4.1          Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.5          Impact Analysis

6.           In-Vitro Diagnostics Market – Asia Pacific Analysis

6.1          Asia Pacific In-Vitro Diagnostics Market Revenue Forecasts and Analysis

7.           Asia Pacific In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services

7.1          Overview

7.2          In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

7.3          Reagents & Kits

7.3.1          Overview

7.3.2          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

7.4          Instruments

7.4.1          Overview

7.4.2          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

7.5          Software & Services

7.5.1          Overview

7.5.2          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

8.           Asia Pacific In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology

8.1          Overview

8.2          In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)

8.3          Immunoassay/Immunochemistry

8.3.1          Overview

8.3.2          Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.4          Clinical Chemistry

8.4.1          Overview

8.4.2          Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.5          Molecular Diagnostics

8.5.1          Overview

8.5.2          Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

8.6          Microbiology

8.6.1          Overview

8.6.2          Microbiology Market Revenue and Forecast to 2027 (US$ Mn)

8.7          Blood Glucose Self-Monitoring

8.7.1          Overview

8.7.2          Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)

8.8          Coagulation and Hemostasis

8.8.1          Overview

8.8.2          Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)

8.9          Haematology

8.9.1          Overview

8.9.2          Haematology Market Revenue and Forecast to 2027 (US$ Mn)

8.10        Urinalysis

8.10.1        Overview

8.10.2        Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)

8.11        Others

8.11.1        Overview

8.11.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.           Asia Pacific In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application

9.1          Overview

9.2          In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)

9.3          Infectious Diseases

9.3.1          Overview

9.3.2          Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.4          Diabetes

9.4.1          Overview

9.4.2          Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9.5          Oncology

9.5.1          Overview

9.5.2          Oncology Market Revenue and Forecast to 2027 (US$ Mn)

9.6          Cardiology

9.6.1          Overview

9.6.2          Cardiology Market Revenue and Forecast to 2027 (US$ Mn)

9.7          Autoimmune Disease

9.7.1          Overview

9.7.2          Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)

9.8          Nephrology

9.8.1          Overview

9.8.2          Nephrology Market Revenue and Forecast to 2027 (US$ Mn)

9.9          Others

9.9.1          Overview

9.9.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

10.        Asia Pacific In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user

10.1        Overview

10.2        In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

10.3        Hospitals

10.3.1        Overview

10.3.2        Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

10.4        Laboratories

10.4.1        Overview

10.4.2        Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.5        Homecare

10.5.1        Overview

10.5.2        Homecare Market Revenue and Forecast to 2027 (US$ Mn)

10.6        Others

10.6.1        Overview

10.6.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

11.        In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1        Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2027

11.1.1        Overview

11.1.2        Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

11.1.3        China

11.1.3.1          China In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.3.1.1           China In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.3.1.2           China In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.3.1.3           China In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.3.1.4           China In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.4        Japan

11.1.4.1          Japan In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.4.1.1           Japan In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.4.1.2           Japan In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.4.1.3           Japan In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.4.1.4           Japan In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.5        India

11.1.5.1          India In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.5.1.1           India In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.5.1.2           India In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.5.1.3           India In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.5.1.4           India In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.7        Australia

11.1.7.1          Australia In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.7.1.1           Australia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.7.1.2           Australia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.7.1.3           Australia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.7.1.4           Australia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.8        South Korea

11.1.8.1          South Korea In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.8.1.1           South Korea In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.8.1.2           South Korea In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.8.1.3           South Korea In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.8.1.4           South Korea In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.9        Rest of Asia Pacific

11.1.9.1          Rest of Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.9.1.1           Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.9.1.2           Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.9.1.3           Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.9.1.4           Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

12.        Impact Of COVID-19 Pandemic on Asia Pacific In-Vitro Diagnostics Market

12.1        Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Organic Developments Done by The Companies in The Market

13.3        Inorganic Developments Done by The Companies in The Market

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        F. HOFFMANN-LA ROCHE LTD.

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Danaher

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        Siemens AG

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        Sysmex Corporation

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        THERMO FISHER SCIENTIFIC INC.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        BD

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        bioMerieux SA

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        BIO-RAD LABORATORIES INC.

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     QIAGEN

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms

 

LIST OF TABLES

Table 1.              Key launches 2016: By Roche

Table 2.              Incidence Rate Of Cancer in 2018 in China

Table 3.              China In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 4.              China In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 5.              China In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 6.              China In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 7.              Japan In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 8.              Japan In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 9.              Japan In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 10.            Japan In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 11.            India In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 12.            India In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 13.            India In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 14.            India In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 15.            Australia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 16.            Australia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 17.            Australia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 18.            Australia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 19.            South Korea In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 20.            South Korea In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 21.            South Korea In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 22.            South Korea In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 23.            Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 24.            Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 25.            Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 26.            Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 27.            Organic Developments Done by The Companies

Table 28.            Inorganic Developments Done by The Companies

Table 29.            Glossary of Terms, In-Vitro Diagnostics Market

 

LIST OF FIGURES

Figure 1.            In-Vitro Diagnostics Market Segmentation

Figure 2.            Asia Pacific In-Vitro Diagnostics Market Overview

Figure 3.            Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market

Figure 4.            Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market

Figure 5.            India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            In-Vitro Diagnostics Market - Asia Pacific PEST Analysis

Figure 7.            In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.            Asia Pacific In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

Figure 10.          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

Figure 11.          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Figure 12.          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

Figure 13.          In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)

Figure 14.          Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 15.          Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 16.          Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 17.          Microbiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 18.          Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)

Figure 19.          Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 20.          Hematology Market Revenue and Forecast to 2027 (US$ Mn)

Figure 21.          Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 22.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.          In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)

Figure 24.          Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.          Diabetes Market Revenue And Forecast To 2027 (US$ Mn)

Figure 26.          Most Prevalent Forms of Cancers Globally, 2018

Figure 27.          Oncology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 28.          Cardiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 29.          Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)

Figure 30.          Nephrology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 31.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 32.          In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

Figure 33.          Hospitals Market Revenue And Forecast To 2027 (US$ Mn)

Figure 34.          Laboratories Market Revenue And Forecast To 2027 (US$ Mn)

Figure 35.          Homecare Market Revenue And Forecast To 2027 (US$ Mn)

Figure 36.          Others Market Revenue and Forecast to 2027 (US$ Mn)

Figure 37.          Asia Pacific In-Vitro Diagnostics Market Revenue Overview, By Country (2019) (US$ Mn)

Figure 38.          Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

Figure 39.          China In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 40.          Japan In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 41.          India In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 42.          Australia In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 43.          South Korea In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 44.          Rest of Asia Pacific In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 45.          Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 46.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. F. HOFFMANN-LA ROCHE LTD.
  2. DANAHER
  3. ABBOTT
  4. SIEMENS AG
  5. SYSMEX CORPORATION
  6. THERMO FISHER SCIENTIFIC, INC.
  7. BD
  8. BIOMERIEUX SA
  9. BIO-RAD LABORATORIES, INC.
  10. QIAGEN
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific In-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific In-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the in-vitro diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00022120
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing